Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts

Li H, Bauzon DE, Xu XY, Tschesche H, Cao J, Sang QXA (1998)
MOLECULAR CARCINOGENESIS 22(2): 84-94.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ;
Abstract
Membrane type (MT) 1 matrix metalloproteinase (MMP) activates progelatinase A (pro-MMP-2), a type IV collagenase, on the cell surface of tumors; however, its function in breast cancer progression and metastasis is not fully understood. To examine the expression of MT1-MMP in breast cancer cells and fibroblasts, a specific rabbit antibody (Ab) directed against a unique synthetic peptide derived from the human MT1-MMP catalytic domain was produced, purified, and characterized. This Ab is not likely to cross-react with MT2-, MT3-, or MT4-MMP or any other MMPs. MT1-MMP expression and pro-M M P-2 activation were stimulated by concanavalin A in two human breast carcinoma cell lines (BT549 and MDA-MB-231) and in normal human fetal-lung fibroblasts (HFL-1) and were slightly upregulated by breast cancer cell-fibroblast interactions. Both pro-MT1-MMP in plasma membrane (63.4 kDa) and the soluble forms of the enzyme in culture medium (57.6 and 25-30 kDa) were detected by immunoblot analysis, suggesting that cell-surface MT1-MMP exhibits an active conformation without the removal of its propeptide domain and that the mature enzyme is shed into the medium. In breast cancer cells, MT1-MMP and a recombinant catalytic domain of MT1-MMP were unable to activate pro-matrilysin, indicating that MT1-MMP is not a universal activator of all MMPs. MT1-MMP may play an important role in the invasive growth and spread of breast cancer cells by specifically activating pro-MMP-2 to cleave the connective-tissue barrier. Furthermore, use of the specific Ab may aid in the investigation of the role of MT1-MMP in human tumors. Mel. Carcinog. 22:84-94, 1998. (C) 1998 Wiley-Liss, Inc.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Li H, Bauzon DE, Xu XY, Tschesche H, Cao J, Sang QXA. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts. MOLECULAR CARCINOGENESIS. 1998;22(2):84-94.
Li, H., Bauzon, D. E., Xu, X. Y., Tschesche, H., Cao, J., & Sang, Q. X. A. (1998). Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts. MOLECULAR CARCINOGENESIS, 22(2), 84-94.
Li, H., Bauzon, D. E., Xu, X. Y., Tschesche, H., Cao, J., and Sang, Q. X. A. (1998). Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts. MOLECULAR CARCINOGENESIS 22, 84-94.
Li, H., et al., 1998. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts. MOLECULAR CARCINOGENESIS, 22(2), p 84-94.
H. Li, et al., “Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts”, MOLECULAR CARCINOGENESIS, vol. 22, 1998, pp. 84-94.
Li, H., Bauzon, D.E., Xu, X.Y., Tschesche, H., Cao, J., Sang, Q.X.A.: Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts. MOLECULAR CARCINOGENESIS. 22, 84-94 (1998).
Li, H, Bauzon, DE, Xu, XY, Tschesche, Harald, Cao, J, and Sang, QXA. “Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts”. MOLECULAR CARCINOGENESIS 22.2 (1998): 84-94.
This data publication is cited in the following publications:
This publication cites the following data publications:

14 Citations in Europe PMC

Data provided by Europe PubMed Central.

The role of matrix metalloproteinases 2 and 9 during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide.
Fracalossi AC, Miranda SR, Oshima CT, Franco M, Ribeiro DA., J. Mol. Histol. 41(1), 2010
PMID: 20213142
The inactive 44-kDa processed form of membrane type 1 matrix metalloproteinase (MT1-MMP) enhances proteolytic activity via regulation of endocytosis of active MT1-MMP.
Cho JA, Osenkowski P, Zhao H, Kim S, Toth M, Cole K, Aboukameel A, Saliganan A, Schuger L, Bonfil RD, Fridman R., J. Biol. Chem. 283(25), 2008
PMID: 18413312
Expression and prognostic role of MMP2, MMP9, MMP13, and MMP14 matrix metalloproteinases in sinonasal and oral malignant melanomas.
Kondratiev S, Gnepp DR, Yakirevich E, Sabo E, Annino DJ, Rebeiz E, Laver NV., Hum. Pathol. 39(3), 2008
PMID: 18045645
MT1-MMP shedding involves an ADAM and is independent of its localization in lipid rafts.
Toth M, Sohail A, Mobashery S, Fridman R., Biochem. Biophys. Res. Commun. 350(2), 2006
PMID: 17007816
ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
Zhong J, Gencay MM, Bubendorf L, Burgess JK, Parson H, Robinson BW, Tamm M, Black JL, Roth M., J. Cell. Physiol. 207(2), 2006
PMID: 16447244
Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP).
Osenkowski P, Toth M, Fridman R., J. Cell. Physiol. 200(1), 2004
PMID: 15137052
Protein engineering and properties of human metalloproteinase and thrombospondin 1.
Wei P, Zhao YG, Zhuang L, Hurst DR, Ruben S, Sang QX., Biochem. Biophys. Res. Commun. 293(1), 2002
PMID: 12054626
Collaborative interactions between neutrophil elastase and metalloproteinases in extracellular matrix degradation in three-dimensional collagen gels.
Zhu Y, Liu X, Skold CM, Wang H, Kohyama T, Wen FQ, Ertl RF, Rennard SI., Respir. Res. 2(5), 2001
PMID: 11686900
Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP.
Hernandez-Barrantes S, Shimura Y, Soloway PD, Sang QA, Fridman R., Biochem. Biophys. Res. Commun. 281(1), 2001
PMID: 11178970

48 References

Data provided by Europe PubMed Central.


Harlow, 1988
The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation.
Stetler-Stevenson WG, Krutzsch HC, Wacher MP, Margulies IM, Liotta LA., J. Biol. Chem. 264(3), 1989
PMID: 2536363
Thrombin induces the activation of progelatinase A in vascular endothelial cells. Physiologic regulation of angiogenesis.
Zucker S, Conner C, DiMassmo BI, Ende H, Drews M, Seiki M, Bahou WF., J. Biol. Chem. 270(40), 1995
PMID: 7559545
Enrichment of collagen and gelatin degrading activities in the plasma membranes of human cancer cells.
Zucker S, Wieman JM, Lysik RM, Wilkie D, Ramamurthy NS, Golub LM, Lane B., Cancer Res. 47(6), 1987
PMID: 3545450
Identification of type IV collagenase in rat testicular cell culture: influence of peritubular-Sertoli cell interactions.
Sang QX, Stetler-Stevenson WG, Liotta LA, Byers SW., Biol. Reprod. 43(6), 1990
PMID: 1963327
Secreted metalloproteinases in testicular cell culture.
Sang QX, Dym M, Byers SW., Biol. Reprod. 43(6), 1990
PMID: 2127232
Basic local alignment search tool.
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ., J. Mol. Biol. 215(3), 1990
PMID: 2231712
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ., Nucleic Acids Res. 25(17), 1997
PMID: 9254694
Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2.
Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M, Okada Y., Cancer Res. 56(12), 1996
PMID: 8665498
Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate.
Lohi J, Lehti K, Westermarck J, Kahari VM, Keski-Oja J., Eur. J. Biochem. 239(2), 1996
PMID: 8706726
Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2.
Strongin AY, Marmer BL, Grant GA, Goldberg GI., J. Biol. Chem. 268(19), 1993
PMID: 8314771
Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP).
Sato H, Takino T, Kinoshita T, Imai K, Okada Y, Stetler Stevenson WG, Seiki M., FEBS Lett. 385(3), 1996
PMID: 8647259
Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R, Toth M, Pena D, Mobashery S., Cancer Res. 55(12), 1995
PMID: 7780967
Induction of membrane-type matrix metalloproteinase 1 (MT1-MMP) expression in human fibroblasts by breast adenocarcinoma cells.
Polette M, Gilles C, Marchand V, Seiki M, Tournier JM, Birembaut P., Clin. Exp. Metastasis 15(2), 1997
PMID: 9062392
Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease.
Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI., J. Biol. Chem. 270(10), 1995
PMID: 7890645

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 9655252
PubMed | Europe PMC

Search this title in

Google Scholar